secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0000105770-21-000080
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma Q3 net sales $706.5M (+28.9%); adj. EPS $2.06 (+79%); raises FY guidance, dividend up 5.9%
--------------------------------------------------------------------------------

- Net sales of $706.5M grew 28.9% (organic +27.9%); reported diluted EPS $2.31 (+112%).
- Adjusted diluted EPS of $2.06 increased 79% YoY.
- Proprietary Products segment sales grew 36.9% to $577M; HVP portfolio led growth.
- Full-year 2021 net sales guidance raised to $2.800-$2.810B; adj. EPS to $8.40-$8.50.
- Quarterly dividend increased 5.9% to $0.18/share, payable Nov 17, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/0000105770-21-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/wst-20211028.htm
  HTML page:      https://secwatch.observer/filing/0000105770-21-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer